SCHEMBL8617534

SCHEMBL8617534

N=C(N)NC(=O)c1cc(-c2cccc(C(F)(F)F)c2)nc2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.64
CA1 P00915 3/20 0.64
CA2 P00918 3/20 0.64
CA9 Q16790 3/20 0.64
TACR3 P29371 5/20 0.54
TP53 P04637 1/20 0.51
MAPT P10636 1/20 0.51
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KCNH2 Q12809 2/20 0.50
HPGD P15428 1/20 0.50
CYP3A4 P08684 1/20 0.50
TRPV1 Q8NER1 1/20 0.49
RUVBL1 Q9Y265 1/20 0.49
PTGER4 P35408 1/20 0.48
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
AKR1C1 Q04828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618210 0.89 RUVBL1 (0.56) CA12CA1CA2CA9TACR3
SCHEMBL8617743 0.86 CYP3A4 (0.65) CA12CA1CA2CA9TACR3
SCHEMBL8619426 0.86 TACR3 (0.55) CA12CA1CA2CA9TACR3
SCHEMBL8615253 0.86 CYP3A4 (0.53) CA12CA1CA2CA9TACR3
SCHEMBL2372402 0.85 CA12 (0.63) CA12CA1CA2CA9TACR3
Hydrochloric Acid SCHEMBL8620745 0.85 CYP3A4 (0.64) TACR3ALDH1A1KDM4EMEN1KMT2A
SCHEMBL8617790 0.85 KDM4E (0.54) CA12CA1CA2CA9TACR3
SCHEMBL8614859 0.84 AKR1C3 (0.67) CA12CA1CA2CA9TACR3
SCHEMBL8614339 0.84 CYP3A4 (0.54) CA12CA1CA2CA9TACR3
SCHEMBL8615217 0.84 TACR3 (0.53) CA12CA1CA2CA9TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed